CLINICAL_TRIALS
trial_result
· 2014-06-20
Clinical Trial Update: The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma [EARLY_Phase 1]
Summary
This EARLY Phase 1 trial assesses the use of gadoxetate disodium (Eovist)–enhanced CT to evaluate cholangiocarcinoma, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Cholangiocarcinoma | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2014-06-20